摘要
Carotid artery angioplasty and stenting （CAS） has been performed with increasing frequency for the treatment of extracranial carotid occlusive diseases （ECOD） in recent years. Its feasibility and safety are supported by the Stenting and Angioplasty with Protection in Patient at High Risk for Endarterectomy （SAPPHIRE） trial,1 which revealed a lower incidence of death, stroke and myocardial infarction compared with carotid endarterectomy （CEA） in high-risk patients. However, it is a pity that up to now, initial results of this endovascular procedure have yet been infrequently documented in China. This retrospective study was to analyze the short-term results of CAS to treat ECOD in a single medical center.
Carotid artery angioplasty and stenting （CAS） has been performed with increasing frequency for the treatment of extracranial carotid occlusive diseases （ECOD） in recent years. Its feasibility and safety are supported by the Stenting and Angioplasty with Protection in Patient at High Risk for Endarterectomy （SAPPHIRE） trial,1 which revealed a lower incidence of death, stroke and myocardial infarction compared with carotid endarterectomy （CEA） in high-risk patients. However, it is a pity that up to now, initial results of this endovascular procedure have yet been infrequently documented in China. This retrospective study was to analyze the short-term results of CAS to treat ECOD in a single medical center.
